Planet 13 Holdings GAAP EPS of -$0.02 misses by $0.01, revenue of $23.08M beats by $0.1M

Planet 13 Holdings reported Q3 GAAP EPS of -$0.02, missing estimates by $0.01, while revenue of $23.08M exceeded expectations by $0.1M, down 0.9% year-over-year. The company released the financial results in a press statement.

Original reporting
Published Nov 13, 2026, 6:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 6:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PLNH
Neutral
high confidence
Mentioned
$PLNH
Relevance
6/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$PLNHNeutralMed
01

Why it matters

The earnings numbers are the first public disclosure for this quarter, providing fresh data for traders.

02

Market read

The report offers new earnings data for a micro‑cap cannabis stock, likely influencing short‑term price action.

03

What to watch

One‑time expenses or inventory adjustments may have driven the EPS miss, not core operational weakness.

Relevance 6/10Novelty 8/10Timing: after-hours

Background

Planet 13 Holdings released its Q3 2026 earnings via a press release, highlighting a slight EPS miss and a marginal revenue beat.

Company-level read

Ticker impact

$PLNHNeutralHigh confidence
Context

Q3 GAAP EPS of -$0.02 missed expectations while revenue of $23.08M beat estimates.

Expected impact

potential modest downside as EPS miss outweighs revenue beat

Evidence & confidence

Investors focus on earnings per share; a miss often triggers sell pressure even when revenue is slightly ahead.

Market effects

minor impact on the cannabis retail sector as peers may be compared to the miss

U.S. market reaction likely limited to small‑cap investors

low global relevance beyond niche cannabis investors

Counterpoint

Revenue beat could signal underlying growth, suggesting a buying opportunity despite EPS miss.

Key entities

  • Planet 13 Holdings Inc.

    U.S.-listed cannabis retailer (ticker PLNH).

Related articles

$PLNHMed

Planet 13 Announces Q3 2026 Financial Results

Planet 13 Holdings Inc. (PLNH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Planet 13 Announces Q3 2026 Financial Results ● Q3 2026 Revenue of $23.1 million ● Q3 2026 Net loss of $6.4 million ● Q3 2026 Adjusted EBITDA loss of $0.2 million All figures are reported in United States dollars ($) unless otherwise indicated Las Vegas, Nevada – Nov

$PLNHMed

Planet 13 Announces Q2 2026 Financial Results

Planet 13 Holdings Inc. (PLNH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Planet 13 Announces Q2 2026 Financial Results ● Q2 2026 Revenue of $22.9 million ● Q2 2026 Net loss of $5.6 million ● Q2 2026 Adjusted EBITDA loss of $0.5 million All figures are reported in United States dollars ($) unless otherwise indicated Las Vegas, Nevada – Aug

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.